CAMBRIDGE, Mass. and AVENTURA, Fla., May 13, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic off-the-shelf gene-edited Chimeric Antigen Receptor (CAR)-NK cells derived from induced pluripotent stem cells (iPSCs) and NK cell engager multifunctional antibodies, announced today that Jason Aryeh, a long time biotech investor and board director, has been elected to the Cytovia Board of Directors, effective immediately
Stem Cell and Regenerative Therapy Market research report provides the details about Industry Chain structure, Market Competition, Market Size & Share, SWOT Analysis, Technology, Cost, Raw Materials, Consumer Preference, Development & Trends, Regional Forecast, Company & Profile, and Product & Service.
Coral reefs face myriad stressors, from pollution to climate change. Understanding how they respond to these threats on a molecular level is essential for predicting what will happen to them in the years to come and devising the best means of protecting them, says Tali Mass, a marine ecologist at the University of Haifa in Israel. Unfortunately, relatively scant knowledge about the different cell types in their bodies has hindered that kind of research
You are here: 12 May 2021 PhD student Meg McFetridge has received a coveted Fulbright Future Scholarship Meg McFetridge was first inspired by mechanobiology in her honours year, watching stem cells on hydrogel surfaces. One end of the hydrogel was soft, the other end stiff, with a stiffness gradient in between
Virtual reality is amongst the revolutionary trends driving the healthcare industry.
An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 children born with a rare and deadly inherited disorder that leaves them without an immune system. Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in the ADA gene that creates the enzyme adenosine deaminase, which is essential to a functioning immune system
Appia co-founder and chief executive officer, JJ Kang/Photo Courtesy of Appia Bio Backed by $52 million in Series A financing led by 8VC and named after a feat of engineering in ancient Rome, Appia Bio jumped into the cell therapy fray this morning with a promising scalable technology platform.
SAN FRANCISCO, May 12, 2021 /PRNewswire/ -- The global advanced therapy medicinal products marketsize is expected to reach USD 21.2billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028.The ATMPs (Advanced Therapy Medicinal Products) exhibit the potential to cure diseases by addressing their root cause rather than symptomatic treatment
Bio-entrepreneur Dr Subhadra Dravida is inspired by Paulo Coelho. Her favourite line is from The Alchemist When you seek something, all the Universe conspires in helping you to achieve it
Intel Market Report presents a comprehensive report on the Stem Cell Therapy Market comprising all the key factors impacting the industry and the overall growth. They include the industry drivers, opportunities, challenges, prevailing trends, and restraints that help the business owners, marketing personnel, and stakeholders, and customers to plan effective strategies and achieve their short-term goals smoothly. The report involves extensive study of the historical data with detailed statistics to help the readers determine future scope of the Stem Cell Therapy market with respect to key opportunities.
Recent Comments